US equities
|
MU
$942.43
▼-4.71%
META
$761.98
▲+2.56%
NVDA
$226.14
▼-0.08%
SNDK
$1,455.95
▼-2.11%
AAPL
$344.19
▲+0.94%
SPCX
$158.28
▼-3.14%
MSFT
$545.92
▲+0.88%
AMD
$595.12
▲+0.15%
MU
$942.43
▼-4.71%
META
$761.98
▲+2.56%
NVDA
$226.14
▼-0.08%
SNDK
$1,455.95
▼-2.11%
AAPL
$344.19
▲+0.94%
SPCX
$158.28
▼-3.14%
MSFT
$545.92
▲+0.88%
AMD
$595.12
▲+0.15%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Justin Hanka
Recent news which mentions Justin Hanka
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
May 14, 2024
Tickers
ENVB
NEWS
Tags
Justin Hanka
Novel Psilocin Prodrugs
Microdosing
From
Benzinga
MindBio Begins Recruitment Of Participants For LSD-Microdosing Clinical Trial In Cancer Patients Experiencing Emotional Distress
July 25, 2023
Tags
Market News
Markets
premium
From
Benzinga
MindBio Phase 2 LSD-Microdosing Clinical Trial In Patients With Major Depressive Disorder Begins Pre-Screening Participants
July 19, 2023
Tags
Market News
mindbio therapeutics
premium
From
Benzinga